| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3104 | |||||||||||||||||||||||
| Submitter : | Mrs. Nancy Hawn | Date & Time: | 12/14/2006 11:12:05 | |||||||||||||||||||||
| Organization : | Mrs. Nancy Hawn | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I strongly object to aborted fetal cell lines for future vaccine development. Also, I understand that chicken pox vaccine is required for school and an ethical alternative does not currently exist. I demand that vaccines be developed which do not use embrionic stem cells or aborted fetal cells in research or development. | ||||||||||||||||||||||||